Contact: Jeremy Craig, 404-413-1357
ATLANTA – Georgia State University Provost Risa Palm announced today (April 13) that Dr. James Weyhenmeyer will assume the role of Vice President for Research and Economic Development, beginning June 15.
Dr. Weyhenmeyer, who is currently Senior Vice Provost for Research and Economic Development in the Office of the Provost of the State University of New York system, succeeds Dr. Robin Morris, who will assume the position of Associate Provost for Strategic Initiatives and Innovation.
“We look forward to working with Dr. Weyhenmeyer to make great strides in advancing research at Georgia State University and to accomplish the research and economic development goals of the University Strategic Plan,” Palm said. “He will be making two trips to our campus prior to June 15, to begin the transition of leadership. President Becker and I ask you to join us in welcoming Dr. Weyhenmeyer to our university community.”
In addition, Dr. Weyhenmeyer currently serves as Managing Director of the Technology Accelerator Fund and Vice President for Research of the Research Foundation of the State University of New York.
“This is an exciting time to be joining Georgia State University,” Dr. Weyhenmeyer said. “I look forward to drawing from my experiences and working with faculty and staff across the system to realize the research and economic development goals of the University’s Strategic Plan.”
He was previously at the University of Illinois at Urbana-Champaign as Vice President for Technology and Economic Development, and served in other senior leadership roles at the University of Illinois.
Dr. Weyhenmeyer is a tenured professor of biological sciences at the University of Albany/State University of New York as well as a member of the Institute for RNA Science and Technology at the University of Albany; he also served as a professor of Cell and Developmental/Structural Biology and Neuroscience at the University of Illinois at Urbana-Champaign.
In 2007, Dr. Weyhenmeyer was named as a foreign member of the Royal Swedish Academy of Engineering Sciences, and has garnered several honors from the American Heart Association. He is a member of the American Heart Association’s Stroke and Cardiology councils, as well as the International Biotechnology Industry Organization.